Liver cirrhosis is a major healthcare problem worldwide with a high mortality which is predominantly caused by complications of portal hypertension, e.g. variceal bleeding and ascites. Reduction of the portal pressure by implantation of a transjugular intrahepatic portosystemic shunt (TIPS) is the key in…
A dedicated clinical school in rare immune mediated liver diseases including PBC, AIH, PSC, IgG4 related disease, liver disease in patients with primary immunodeficiency and those treated with immune checkpoint inhibitors. The course will follow an inverted classroom model and…
The 2022 EASL-AASLD Masterclass provides a unique educational collaboration of clinical, basic, and translational scientists from leading academic medical institutions from both sides of the Atlantic. Participants will attend a two-day intensive training session designed for future leaders in academic…
